发明授权
- 专利标题： Conjugate of an antibody against CCR5 and an antifusogenic peptide
- 专利标题（中）： 抗CCR5抗体和抗融合肽的缀合物
-
申请号： US11893899申请日： 2007-08-17
-
公开(公告)号： US07951920B2公开(公告)日： 2011-05-31
- 发明人: Michael Brandt , Stephan Fischer , Erhard Kopetzki , Suryanarayana Sankuratri , Ralf Schumacher
- 申请人： Michael Brandt , Stephan Fischer , Erhard Kopetzki , Suryanarayana Sankuratri , Ralf Schumacher
- 申请人地址： US CA Palo Alto
- 专利权人： Roche Palo Alto LLC
- 当前专利权人： Roche Palo Alto LLC
- 当前专利权人地址： US CA Palo Alto
- 代理商 Robert C. Hall
- 优先权： EP06017156 20060817; EP06020647 20060929
- 主分类号： C07K17/00
- IPC分类号： C07K17/00 ; C07K17/14 ; C12P21/08 ; A61K39/00
摘要：
The current invention is related to a conjugate comprising one or more antifusogenic peptides and an anti-CCR5 antibody (mAb CCR5) characterized in that one to eight antifusogenic peptides are each conjugated to one terminus of the heavy and/or light chains of the anti-CCR5 antibody and to the pharmaceutical use of the conjugate.
公开/授权文献
信息查询
